BIOGY
Price
$9.75
Change
-$0.40 (-3.94%)
Updated
Jul 15 closing price
Capitalization
1B
BIOVF
Price
$29.79
Change
-$0.00 (-0.00%)
Updated
Jul 17 closing price
Capitalization
5.81B
Interact to see
Advertisement

BIOGY vs BIOVF

Header iconBIOGY vs BIOVF Comparison
Open Charts BIOGY vs BIOVFBanner chart's image
Biogaia AB
Price$9.75
Change-$0.40 (-3.94%)
Volume$1K
Capitalization1B
Swedish Orphan Biovitrum AB
Price$29.79
Change-$0.00 (-0.00%)
Volume$200
Capitalization5.81B
BIOGY vs BIOVF Comparison Chart in %
Loading...
BIOGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIOVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BIOGY vs. BIOVF commentary
Aug 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BIOGY is a Buy and BIOVF is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 08, 2025
Stock price -- (BIOGY: $9.75 vs. BIOVF: $29.79)
Brand notoriety: BIOGY and BIOVF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: BIOGY: 147% vs. BIOVF: 30%
Market capitalization -- BIOGY: $1B vs. BIOVF: $5.81B
BIOGY [@Pharmaceuticals: Other] is valued at $1B. BIOVF’s [@Pharmaceuticals: Other] market capitalization is $5.81B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.91B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BIOGY’s FA Score shows that 1 FA rating(s) are green whileBIOVF’s FA Score has 0 green FA rating(s).

  • BIOGY’s FA Score: 1 green, 4 red.
  • BIOVF’s FA Score: 0 green, 5 red.
According to our system of comparison, BIOGY is a better buy in the long-term than BIOVF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BIOGY’s TA Score shows that 4 TA indicator(s) are bullish while BIOVF’s TA Score has 4 bullish TA indicator(s).

  • BIOGY’s TA Score: 4 bullish, 4 bearish.
  • BIOVF’s TA Score: 4 bullish, 1 bearish.
According to our system of comparison, BIOVF is a better buy in the short-term than BIOGY.

Price Growth

BIOGY (@Pharmaceuticals: Other) experienced а 0.00% price change this week, while BIOVF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.43%. For the same industry, the average monthly price growth was +7.35%, and the average quarterly price growth was +81.90%.

Industries' Descriptions

@Pharmaceuticals: Other (+2.43% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BIOVF($5.81B) has a higher market cap than BIOGY($1B). BIOGY has higher P/E ratio than BIOVF: BIOGY (25.13) vs BIOVF (19.92). BIOVF YTD gains are higher at: 7.701 vs. BIOGY (4.332). BIOVF has higher annual earnings (EBITDA): 6.96B vs. BIOGY (529M). BIOGY has more cash in the bank: 1.37B vs. BIOVF (790M). BIOVF has higher revenues than BIOGY: BIOVF (20.1B) vs BIOGY (1.21B).
BIOGYBIOVFBIOGY / BIOVF
Capitalization1B5.81B17%
EBITDA529M6.96B8%
Gain YTD4.3327.70156%
P/E Ratio25.1319.92126%
Revenue1.21B20.1B6%
Total Cash1.37B790M173%
Total DebtN/A28.2B-
FUNDAMENTALS RATINGS
BIOGY vs BIOVF: Fundamental Ratings
BIOGY
BIOVF
OUTLOOK RATING
1..100
2947
VALUATION
overvalued / fair valued / undervalued
1..100
7
Undervalued
78
Overvalued
PROFIT vs RISK RATING
1..100
8355
SMR RATING
1..100
4364
PRICE GROWTH RATING
1..100
5753
P/E GROWTH RATING
1..100
4092
SEASONALITY SCORE
1..100
4585

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BIOGY's Valuation (7) in the null industry is significantly better than the same rating for BIOVF (78). This means that BIOGY’s stock grew significantly faster than BIOVF’s over the last 12 months.

BIOVF's Profit vs Risk Rating (55) in the null industry is in the same range as BIOGY (83). This means that BIOVF’s stock grew similarly to BIOGY’s over the last 12 months.

BIOGY's SMR Rating (43) in the null industry is in the same range as BIOVF (64). This means that BIOGY’s stock grew similarly to BIOVF’s over the last 12 months.

BIOVF's Price Growth Rating (53) in the null industry is in the same range as BIOGY (57). This means that BIOVF’s stock grew similarly to BIOGY’s over the last 12 months.

BIOGY's P/E Growth Rating (40) in the null industry is somewhat better than the same rating for BIOVF (92). This means that BIOGY’s stock grew somewhat faster than BIOVF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BIOGYBIOVF
RSI
ODDS (%)
Bearish Trend 2 days ago
17%
N/A
Stochastic
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
59%
Momentum
ODDS (%)
Bullish Trend 2 days ago
38%
Bullish Trend 2 days ago
47%
MACD
ODDS (%)
Bearish Trend 2 days ago
30%
Bullish Trend 2 days ago
49%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
37%
Bullish Trend 2 days ago
48%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
35%
Bullish Trend 2 days ago
44%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
38%
Bearish Trend 2 days ago
52%
Aroon
ODDS (%)
Bearish Trend 2 days ago
30%
Bullish Trend 2 days ago
42%
View a ticker or compare two or three
Interact to see
Advertisement
BIOGY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BIOVF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WLTTX12.06N/A
N/A
Wilshire International Equity Instl
TIRRX11.29N/A
N/A
T. Rowe Price Real Estate I
PJFOX72.15N/A
N/A
PGIM Jennison Growth R2
FIKWX12.38N/A
N/A
Fidelity Advisor Asset Manager 30% Z
WAFMX3.73-0.01
-0.27%
Wasatch Frontier Emerg Sm Countrs Inv

BIOGY and

Correlation & Price change

A.I.dvisor tells us that BIOGY and BIOVF have been poorly correlated (+11% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOGY and BIOVF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOGY
1D Price
Change %
BIOGY100%
N/A
BIOVF - BIOGY
11%
Poorly correlated
N/A
ARSUF - BIOGY
2%
Poorly correlated
N/A
BKUH - BIOGY
1%
Poorly correlated
N/A
CANN - BIOGY
-0%
Poorly correlated
-7.07%
CAIHF - BIOGY
-0%
Poorly correlated
N/A
More

BIOVF and

Correlation & Price change

A.I.dvisor tells us that BIOVF and INNPF have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BIOVF and INNPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BIOVF
1D Price
Change %
BIOVF100%
N/A
INNPF - BIOVF
20%
Poorly correlated
-99.16%
APNHY - BIOVF
19%
Poorly correlated
-3.46%
BIOGY - BIOVF
11%
Poorly correlated
N/A
BOIRF - BIOVF
1%
Poorly correlated
-15.79%
ARSUF - BIOVF
1%
Poorly correlated
N/A
More